Local Effect of Intranasal Beclomethasone Dipropionate Aerosol in Hay Fever
Open Access
- 24 November 1973
- Vol. 4 (5890) , 464-466
- https://doi.org/10.1136/bmj.4.5890.464
Abstract
The effect of a daily dose of 400 μg beclomethasone dipropionate aerosol intranasally has been investigated in a double-blind cross-over trial in 29 patients with hay fever. The effect on the nasal symptoms was so pronounced in 25 patients that further symptomatic treatment was unnecessary. Beclomethasone dipropionate aerosol had, on the other hand, no direct effect on itching in the eyes, which is in accordance with the fact that biochemical investigations did not show any sign of suppression of the adrenal function. It is concluded that beclomethasone dipropionate aerosol intranasally is an effective and apparently harmless way of controlling the nasal symptoms in hay fever.Keywords
This publication has 11 references indexed in Scilit:
- Aerosol beclomethasone dipropionate in chronic bronchial asthma.1973
- Recovery of Adrenal Function after Substitution of Beclomethasone Dipropionate for Oral CorticosteroidsBMJ, 1973
- Comparison of Beclomethasone Dipropionate Aerosol and Prednisolone in Reversible Airways ObstructionBMJ, 1972
- Beclomethasone Dipropionate: A New Steroid Aerosol for the Treatment of Allergic AsthmaBMJ, 1972
- Comparison of Preseasonal and Coseasonal Allpyral with Depo-Medrone in Summer Hay-feverBMJ, 1969
- Adrenal function during the use of dexamethasone aerosols in the treatment of ragweed hay feverJournal of Allergy, 1967
- Suppression of hay fever symptoms with intranasal dexamethasone aerosolJournal of Allergy, 1965
- A METHOD FOR THE ANALYSIS OF URINARY 17-HYDROXYCORTICOSTEROIDSJournal of Endocrinology, 1961
- PREDNISOLONE SNUFF IN HAY-FEVER: A CONTROLLED TRIALThe Lancet, 1957
- HYDROCORTISONE IN TREATMENT OF ALLERGIC CONJUNCTIVITIS, ALLERGIC RHINITIS, AND BRONCHIAL ASTHMAThe Lancet, 1955